Cohance Lifesciences Ltd. Conference Calls and Earnings Call Transcripts

Cohance Lifesciences Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Cohance Lifesciences Ltd.
30 Dec 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the conference call for the investors held on December 26, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
27 Dec 2022
993.95
0.41%
Management Call: Suven Pharma Acquisition by Advent International
Conference Call with Suven Pharma Management and Analysts on the acquisition of the Jasti family stake by Advent International. Listen to the transcript.
video
audio
 
logo
Cohance Lifesciences Ltd.
27 Dec 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our conference call intimation dated December 26, 2022, that audio recording of the conference call for the investors held on Monday, December 26, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events
pdf
logo
Cohance Lifesciences Ltd.
15 Nov 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and half-year ended September 30, 2022 conducted after the meeting of Board of Directors held on November 8, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
10 Nov 2022, 03:00PM
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated November 3, 2022, that audio recording of the conference call for the quarter and half-year ended September 30, 2022 held on Wednesday, November 9, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
10 Nov 2022, 11:40AM
993.95
0.41%
Results Earnings Call for Q2FY23 of Suven Pharmaceuticals
Conference Call with Suven Pharmaceuticals Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Cohance Lifesciences Ltd.
16 Aug 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on August 8, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
09 Aug 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated August 4, 2022, that audio recording of the conference call for the quarter ended June 30, 2022 held on Monday, August 8, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release In view of the above, please further note that Trading Window will be opened from 11th August, 2022 instead of 13th August, 2022 as intimated earlier through our Notice of Board Meeting dated 1st August, 2022. This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
08 Jun 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 read with Para-A of Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the Analyst / Institutional Investor Meeting held on June 1, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events This is for your information and record.
pdf
logo
Cohance Lifesciences Ltd.
02 Jun 2022
993.95
0.41%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Analyst / Institutional Investor Meeting intimation dated May 31, 2022, that audio recording of the Analyst / Institutional Investor Meeting held on June 1, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events This is for your information and record.
pdf

Earnings Calls Podcast on